We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 123

AG opinion on medical devices qualification issues for e-health software products

  • CMS Cameron McKenna
  • -
  • European Union, Germany
  • -
  • May 21 2012

On 15 May 2012, the Advocate General published his Opinion in the European Court of Justice reference in Brain Products GmbH v BioSemi VOF and Others by the German Supreme Court (Bundesgerichtshof

A consistently broad interpretation of "health claim" emerges in Europe

  • Taylor Wessing
  • -
  • European Union, Germany
  • -
  • April 30 2014

A decision recently handed down by the German Federal Court of Justice (Bundesgerichtshof - BGH) has confirmed the broad interpretation of the term

Criteria for search engine AdWords advertising defined by Federal Supreme Court

  • Baker & McKenzie
  • -
  • Germany
  • -
  • March 17 2014

The questions of whether pharmaceutical companies in Germany are permitted to advertise OTC products through search engine AdWords advertising, and if

Joint Senate of the Federal Court of Justice rules: German prescription drug price maintenance also applies to EU mail service pharmacies

  • Oppenhoff & Partner Rechtsanwälte
  • -
  • Germany
  • -
  • September 28 2012

Europa Apotheek, the second largest mail service pharmacy in Europe with its seat in the Netherlands, had offered drugs via Internet mail commerce also for the German market

More freedom in the advertising of medicines: just how much creative freedom actually exists?

  • Oppenhoff & Partner Rechtsanwälte
  • -
  • Germany
  • -
  • November 30 2012

The advertising of medicines and other remedies is strictly regulated by the German Act on Advertising in the Healthcare Sector Heilmittelwerbegesetz, HWG

German court re-enforces incentives ban against manufacturer: no touchpads for increased sales

  • Jones Day
  • -
  • Germany
  • -
  • December 6 2012

Medical device manufacturers whose products more closely resemble consumer goods may be inclined to lose sight of German health care compliance legislation

FSC decides on patentability of neural progenitor cells II (Brustle)

  • Bird & Bird
  • -
  • Germany
  • -
  • February 25 2013

Recently, the German Federal Supreme Court decided on a nullity action on the patentability of progenitor cells extracted from human embryonic stem

The Bolar exemption protection of API suppliers

  • Bird & Bird
  • -
  • European Union, Germany
  • -
  • May 18 2014

The CJEU has recently been asked by the German courts to consider whether the Bolar exemption extends to a third party manufacturer which supplies a

CJEU referral of the Düsseldorf Court of Appeal regarding third party supply for Bolar exemption purposes (now available in English)

  • Taylor Wessing
  • -
  • European Union, Germany
  • -
  • January 14 2014

Last month the Düsseldorf Court of Appeal has referred questions to the CJEU on whether and under what conditions the supply of patent protected

A German perspective on pharmaceutical protection

  • Meissner Bolte & Partner
  • -
  • Germany
  • -
  • December 20 2013

According to information available from the Federal Ministry of Economics and Technology website, for many years the Germany pharmaceutical industry